Cargando…

Intravenous pamidronate for refractory rheumatoid arthritis

BACKGROUND: Patients with rheumatoid arthritis may be resistant to conventional treatment with disease-modifying antirheumatic drugs (DMARDs). On the other hand, biologic therapy is costly and may be inconvenient for many patients. Pamidronate is a potent bisphosphonate with the capacity of modifyin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salesi, Mansour, Mottaghi, Peyman, Karimifar, Mansour, Farajzadegan, Ziba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634265/ https://www.ncbi.nlm.nih.gov/pubmed/23626604

Ejemplares similares

Pamidronate infusion improved two cases of intractable seronegative rheumatoid arthritise
por: Salesi, Mansour, et al.
Publicado: (2011)

The association of anti-CCP1 antibodies with disease activity score 28 (DAS-28) in rheumatoid arthritis
por: Karimifar, Mansoor, et al.
Publicado: (2012)

Serum adenosine deaminase in patients with rheumatoid arthritis treated with methotrexate
por: Salesi, Mansour, et al.
Publicado: (2012)

Intravenous Pamidronate for Refractory Lymphedema
por: Beigi, A A, et al.
Publicado: (2011)

Purified protein derivative test and its booster phenomenon in patients with rheumatoid arthritis
por: Salesi, Mansour, et al.
Publicado: (2015)

The effects of conventional drugs in the treatment of rheumatoid arthritis on the serum lipids
por: Karimifar, Mansoor, et al.
Publicado: (2018)

TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case–Control Study
por: Salesi, Mansour, et al.
Publicado: (2021)

The association of body mass index with disease activity and clinical response to combination therapy in patients with rheumatoid arthritis
por: Mirpourian, Maryam, et al.
Publicado: (2014)

Evaluation of Diagnostic Accuracy of Alpha-Fodrin Antibody in Iranian Patients with Sjogren's Disease
por: Rostamian, Alireza, et al.
Publicado: (2022)

A comparison of rituximab with cyclophosphamide in terms of efficacy and complications as induction therapy for treating granulomatosis with polyangiitis: A three-center study
por: Chaleshtori, Maryam Tavakoli, et al.
Publicado: (2022)

The salivary alpha-amylase concentration in patients with rheumatoid arthritis: A case–control study
por: Pakravan, Fahimeh, et al.
Publicado: (2023)

Effectiveness of bosentan in the treatment of systemic sclerosis-related digital ulcers: Systematic review and meta-analysis
por: Hosseinbalam, Marziyeh, et al.
Publicado: (2023)

Ultrasonographic findings of rheumatoid arthritis patients who are in clinical remission
por: Karimzadeh, Hadi, et al.
Publicado: (2018)

Evaluation of bone loss in diabetic postmenopausal women
por: Karimifar, Mansoor, et al.
Publicado: (2012)

Efficacy of synbiotic supplementation in improving rheumatoid arthritis
por: Esmaeili, Farah, et al.
Publicado: (2020)

Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
por: Lim, Mie Jin, et al.
Publicado: (2010)

Effects of aerobic exercise on hematologic indices of women with rheumatoid arthritis: A randomized clinical trial
por: Shapoorabadi, Yaser Jafari, et al.
Publicado: (2016)

Strong Association of Polymorphism in SPRED2 Gene with Disease Susceptibility and Clinical Characteristics of Rheumatoid Arthritis in the Iranian Population
por: Pakzad, Bahram, et al.
Publicado: (2022)

Association of a Functional Single Nucleotide Polymorphism (rs874040) in the RBPJ Gene with Susceptibility to Rheumatoid Arthritis in Iranian Population
por: Salesi, Mansour, et al.
Publicado: (2021)

High-dose intravenous pamidronate for metastatic bone pain.
por: Purohit, O. P., et al.
Publicado: (1994)

Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients
por: Salesi, Mansour, et al.
Publicado: (2014)

Effectiveness of the treatment with intravenous pamidronate in children with rheumatic diseases
por: Marco, A, et al.
Publicado: (2008)

The relationship between dietary patterns and rheumatoid arthritis: a case–control study
por: Nezamoleslami, Shokufeh, et al.
Publicado: (2020)

Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents
por: Yoon, Ji-Hee, et al.
Publicado: (2021)

Serum cryoglobulins and disease activity in systematic lupus erythematosus
por: Karimifar, Mansoor, et al.
Publicado: (2013)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Letter to the Editor: Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
por: Marcuzzi, Annalisa, et al.
Publicado: (2011)

The Author Response: Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
por: Park, Won
Publicado: (2011)

A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
por: Purohit, O. P., et al.
Publicado: (1995)

Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD).
por: Ling, P. J., et al.
Publicado: (1995)

The Neurological Safety of Epidural Pamidronate in Rats
por: Lee, Pyung Bok, et al.
Publicado: (2010)

ODP094 Hypercalcemia caused by Mycobacterium Avium Complex, with Excellent Response to Intravenous Pamidronate.
por: Khthir, Rodhan
Publicado: (2022)

Therapy with pamidronate in children with osteogenesis imperfecta
por: Marginean, Otilia, et al.
Publicado: (2017)

Prevalence of Chondrocalcinosis in Patients above 50 Years and the Relationship with Osteoarthritis
por: Karimzadeh, Hadi, et al.
Publicado: (2017)

Pleuropulmonary manifestation in patients with rheumatoid arthritis in Saudi Arabia
por: Alamoudi, Omer S. B., et al.
Publicado: (2017)

Single-centre experience of refractory rheumatoid arthritis
por: Fitton, John, et al.
Publicado: (2022)

Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children
por: Juszczak, Bartłomiej, et al.
Publicado: (2021)

Effects of Adding Intravenous Pamidronate to Ongoing Menopausal Hormone Therapy in Postmenopausal Korean Women with Low Bone Mineral Density
por: Koo, Young-Ah, et al.
Publicado: (2019)

Treatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonates
por: Eekman, Danielle A, et al.
Publicado: (2009)

Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial
por: von Au, Alexandra, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0lglbdok1st5i214mski1tqftb